- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.06. | Allurion enacts 1-for-15 reverse stock split for exchange relisting | 2 | Seeking Alpha | ||
| 17.06. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.06. | Allurion Technologies, Inc. Advances Plan to Re-List / Announces a 1-for-15 reverse stock split | 86 | Business Wire | NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (OTCQB: ALUR), a pioneer in metabolically healthy weight loss, today announced a 1-for-15 reverse stock of its outstanding common stock intended... ► Artikel lesen | |
| ALLURION TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 27.05. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.03. | ALLURION TECHNOLOGIES, INC. - 10-K, Annual Report | - | SEC Filings | ||
| 12.03. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.03. | NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) | 255 | Business Wire | NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities... ► Artikel lesen | |
| 02.03. | NYSE initiates delisting proceedings against Allurion | 1 | Investing.com | ||
| 02.03. | NYSE leitet Delisting-Verfahren gegen Allurion ein | 2 | Investing.com Deutsch | ||
| 02.03. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 02.03. | Allurion Technologies, Inc. Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE | 204 | Business Wire | Company's recent FDA approval catalyzes plan to regain compliance with listing requirements of NYSE or another exchange; shares of common stock expected to continue trading on NYSE during appeal process
NATICK... ► Artikel lesen | |
| 02.03. | NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) | 158 | Business Wire | NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities... ► Artikel lesen | |
| 27.02. | Weekly Buzz: MacroGenics' LINNET Trial On Hold; Eton Pharmaceuticals, Allurion Technologies Get FDA Nod; Gilead Sciences Snaps Up Arcellx | 1.339 | AFX News | FOSTER CITY (dpa-AFX) - This week, the biotech space witnessed significant milestones, including FDA approvals, oncology drug acquisitions, and collaborations. Positive clinical trial results... ► Artikel lesen | |
| 25.02. | What's Going On With Allurion Stock On Wednesday? | 1 | Benzinga.com | ||
| 24.02. | Allurion announces exercise of warrants for $3M in gross proceeds | 2 | Seeking Alpha | ||
| 24.02. | Allurion-Aktie: Hochstufung auf "Buy" nach FDA-Zulassung | 5 | Investing.com Deutsch | ||
| 24.02. | Allurion Technologies stock rating upgraded on FDA approval | 2 | Investing.com | ||
| 23.02. | Allurion erhält FDA-Zulassung für Magenballon-System zur Adipositas-Behandlung | 3 | Investing.com Deutsch | ||
| 23.02. | FDA approves Allurion gastric balloon for obesity treatment | 1 | Investing.com | ||
| 23.02. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 14 | SEC Filings |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,310 | -0,65 % | EQS-News: Eckert & Ziegler SE: Hauptversammlung der Eckert & Ziegler SE beschließt deutlich höhere Dividende | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Hauptversammlung/Dividende
Hauptversammlung der Eckert & Ziegler SE beschließt deutlich höhere Dividende
24.06.2026 / 15:44... ► Artikel lesen | |
| GERRESHEIMER | 25,960 | -1,74 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
22.06.2026 / 11:08 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| NETRAMARK | 0,385 | +0,26 % | NetraMark Holdings Inc.: NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum | TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is... ► Artikel lesen | |
| NANO-X IMAGING | 1,100 | +0,92 % | Nano-X tumbles after Q1 revenue miss, going concern risks | ||
| VAREX IMAGING | 9,150 | +1,10 % | Wall Street Analysts Think VAREX IMAGING (VREX) Could Surge 61.6%: Read This Before Placing a Bet | ||
| BRIGHTSPRING HEALTH SERVICES | 68,98 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 28,510 | 0,00 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| SIEMENS HEALTHINEERS | 34,220 | -0,52 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,860 | -0,07 % | AKTIE IM FOKUS: FMC auf Hoch seit Februar - Goldman optimistisch für Quartal | FRANKFURT (dpa-AFX Broker) - Die Aktien von FMC haben am Montag mit 41,58 Euro wieder einen Höchststand seit Februar erreicht. Richard Felton von Goldman Sachs ist optimistisch, dass der Dialysekonzern... ► Artikel lesen | |
| FRESENIUS | 39,820 | -0,72 % | FRESENIUS SE & CO KGAA - Stabilität als Fundament | ||
| TALKSPACE | 5,220 | 0,00 % | NSE - Talkspace, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| HEARTFLOW | 35,680 | +0,08 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,155 | -0,15 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| INVO FERTILITY | 2,440 | -0,41 % | INVO Fertility, Inc.: INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure | 23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet Growth reflects both organic clinic initiatives and acquisition contribution... ► Artikel lesen | |
| BILLIONTOONE | 117,98 | -0,16 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen |
ALLURION TECHNOLOGIES INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALLURION TECHNOLOGIES INC finden Sie auf Wallstreet Online.